MAPT and early-onset autosomal dominant Alzheimer disease: The genetic background also differed from the training sample and corresponds to tau-related neurodegeneration, the accumulation of which contributes to the pathology of Alzheimer disease (Lasagna-Reeves et al., 2016; Rousseaux et al., 2016; Galasso et al., 2017).